Performance Food Group Company (PFGC) /
The cash flow of Performance Food Group Company over the past 10 years
Chart Performance Food Group Company: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2026 Open the chart →In fiscal 2026, the latest fiscal year on file, Performance Food Group Company's operating cash flow was $1.41B and its capital expenditures $384.1M, leaving free cash flow of $1.03B. Free cash flow was above zero in 9 of the 10 years shown. It ranged from -$124.2M in fiscal 2021 to $1.03B in fiscal 2026. Capital expenditures were highest in fiscal 2025, at $506M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2026ended Jun 27, 2026 | $1.41B | $384.1M | $1.03B |
| 2025ended Jun 28, 2025 | $1.21B | $506M | $704.1M |
| 2024ended Jun 29, 2024 | $1.16B | $395.6M | $767.4M |
| 2023ended Jul 1, 2023 | $832.1M | $269.7M | $562.4M |
| 2022ended Jul 2, 2022 | $276.5M | $215.5M | $61M |
| 2021ended Jul 3, 2021 | $64.6M | $188.8M | -$124.2M |
| 2020ended Jun 27, 2020 | $623.6M | $158M | $465.6M |
| 2019ended Jun 29, 2019 | $317.4M | $139.1M | $178.3M |
| 2018ended Jun 30, 2018 | $367M | $140.1M | $226.9M |
| 2017ended Jul 1, 2017 | $201.7M | $140.2M | $61.5M |
Fiscal years as Performance Food Group Company reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Performance Food Group Company
- The revenue of Performance Food Group Company
- The profitability of Performance Food Group Company
- The debt of Performance Food Group Company
- All of Performance Food Group Company's financials, charted
Companies of a similar size
- NBIXNEUROCRINE BIOSCIENCES INC
- WWayfair Inc.
- JAZZJazz Pharmaceuticals plc
- SOLVSOLVENTUM CORPORATION
- RBCRBC BEARINGS INCORPORATED
Not investment advice. This page shows what Performance Food Group Company filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.